Good MorningEquity markets ended January on a solid footing, up for the month and year, putting the S&P 500 on track to hit new all-time highs soon. That could be as soon as next week, given the outlook for earnings reports and the high likelihood of sustained earnings growth in 2025. The critical detail for investors is that a move to new highs is a significant technical signal that could lead the index to advance another 1,200 points this year.
Next week's hurdles include earnings from names like McDonald's, Google, PepsiCo, and Advanced Micro Devices and economic data from the labor markets. Earnings should confirm what has been reported so far for Q4: solid business activity, increased investment in technology, and steady spending supported by healthy labor markets. The only bad news is that inflation remains persistent and will keep the FOMC from cutting rates in the first half, if at all, in 2025. Featured: This Phone Pays People For Using It (Mode Mobile) |
Stocks | |
Starting small is usually good advice when beginning a new endeavor. If you’re trying to get back in shape, a quick run or light workout is a better starting point than a marathon. However, that logic is counterintuitive when it comes to stocks. Bigger stocks tend to be safer and less volati... Read the Full Story |
|
From Our PartnersGrab This Altcoin Before Trump's Crypto Announcement
Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
| | Click here to check it out now |
|
Markets | | The threat of a punishing trade war sent Wall Street on a roller coaster Monday. After initially falling sharply on worries about President Donald Trump’s tariffs, U.S. stocks pared their losses after Mexico said it had negotiated a one-month reprieve.The S&P 500 ended up falling 0.8% after Asia... Read the Full Story |
|
Markets | |
Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line of branded drugs driving growth.
Its specialty medicines address specific conditions, incl... Read the Full Story |
|
From Our PartnersThe two new trades Jim is about to send out only scratch the surface of the profit opportunities you'll see as a Velocity Trader subscriber. Because he's given the people who follow his work the chance to bank gains of 43,508% since November of 2015… including a current streak where he's delivered 712 winners without a single loss. | | Discover how to join them here. |
|
Markets | | For Elon Musk fans, it’s the half a trillion-dollar bet.That is how much the stock market value of Tesla has rocketed since the presidential election, a vertiginous climb uninterrupted in recent days despite a disappointing financial report that would have sunk the stock of nearly any other company.... Read the Full Story |
|
Markets | | Companies in a wide range of industries saw their stocks come under pressure Monday on Wall Street because of tariff threats from President Donald Trump.Automakers, technology companies and retailers all fell as the U.S., Mexico, Canada and China wrangled over tariffs. Trump said over the weekend th... Read the Full Story |
|
From Our PartnersBillionaire Sam Altman has become one of the most powerful men in the world by running OpenAI…
But there’s a far lesser known investment he’s making that could put OpenAI to shame.
In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI…
And the US Military… not to mention hundreds of other giant companies around the globe.
To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office…
Which ordered the government to take this incredible new technology seriously. | | Check out our report right here. |
|
Markets | | Asian shares climbed Tuesday after President Donald Trump said tariffs on Mexico and Canada would be delayed for a month.Stocks across Asia were up Tuesday. The Hang Seng Index in Hong Kong grew 2.10% to 20,642.58. Japan’s benchmark Nikkei 225 was up 1.61% to 39,140.41, while South Korea’s Kospi gre... Read the Full Story |
|
Markets | |
Arguably late to the AI game, Apple’s (NASDAQ: AAPL) understated push into AI has it set up to grow substantially over the next decade. Ultimately, it won’t be about the flashiness of the AI product or launch, but its durability, and Apple has proven to be a durable business. The compa... Read the Full Story |
|
Markets | |
Three S&P 500 Index constituents, as well as one of the world’s biggest names in oil and gas, are raising dividends as 2025 gets started. The firm not in the S&P 500 also announced billions in new buyback authorization. All dividend yield and return metrics use prices as of the Jan. ... Read the Full Story |
|
Markets | | President Donald Trump on Monday signed an executive order directing the U.S. to take steps to start developing a government-owned investment fund that he said could be used to profit off of TikTok if he’s successful at finding the company an American buyer Read the Full Story |
|
Markets | |
The Wall Street Journal pointed out a peculiar new trend on social media, where influencers are not showcasing their lavish purchases but rather going the opposite route, embracing a “No Buy” trend. Consumers are tired of inflation and lofty credit card interest rates and have deemed 2... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia. | Should I Buy Altria Group Stock? MO Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Altria Group was last updated on Monday, February 03, 2025 at 1:05 AM.
Altria Group Bull Case-
Altria Group, Inc. has a strong dividend yield of 7.82%, which can provide a steady income stream for investors. This is particularly attractive in a low-interest-rate environment.
-
The company reported earnings per share of $1.29, exceeding analysts' expectations, indicating strong financial performance and potential for future growth.
-
With a net margin of 42.82%, Altria Group, Inc. demonstrates effective cost management and profitability, which can be appealing to investors looking for financially stable companies.
-
Recent institutional investments show confidence in the company, with 57.41% of the stock owned by institutional investors and hedge funds, suggesting a positive outlook from market experts.
-
The current stock price of Altria Group, Inc. is favorable for entry, allowing investors to potentially benefit from future price appreciation as the company continues to innovate in the tobacco and nicotine product markets.
Altria Group Bear Case-
The company has a negative return on equity of 233.80%, which indicates that it is not generating profit from its equity investments, raising concerns about its financial health.
-
Altria Group, Inc. operates in a declining industry, as smoking rates continue to decrease, which could impact long-term growth prospects.
-
The payout ratio is currently at 68.92%, suggesting that a significant portion of earnings is being paid out as dividends, which may limit reinvestment in the business.
-
Regulatory pressures and changing consumer preferences towards healthier alternatives could pose risks to Altria Group, Inc.'s market position and profitability.
-
Recent market volatility may affect stock performance, and investors should be cautious of potential fluctuations in share price due to external economic factors.
| View Today's Stock Pick |
|